• 검색 결과가 없습니다.

Laparoscopic versus open liver resection for hepatocellular carcinoma: Long-term and short-term surgical outcomes depending on tumor size

N/A
N/A
Protected

Academic year: 2021

Share "Laparoscopic versus open liver resection for hepatocellular carcinoma: Long-term and short-term surgical outcomes depending on tumor size"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

AHBPSAnnals of Hepato-Biliary-Pancreatic Surgery

www.ahbps.org S198

Laparoscopic versus open liver resection for

hepatocellular carcinoma: Long-term and short-term surgical outcomes depending on tumor size

Olesya SOLOVYEVA, Mikhail EFANOV, Ivan KAZAKOV, Andrey VANKOVICH, Dmitriy KOVALENKO, Anna KOROLEVA, Natalia ELIZAROVA, Natalia KULIKOVA, Alexander PETRIN, Ruslan ALIKHANOV*

Department of Hepatobiliary and Pancreatic Surgery, Moscow Clinical Scientific Center, Russia

LV-PP-4-4

Introduction: The aim of the study was to compare the short- and long-term outcomes of laparoscopic liver resection (LLR) and open liver resection (OLR) for hepatocellular carcinoma (HCC) and to identify patients who might gain more benefits from LLR depending on tumor size.

Methods: The demographic and peri-operative data, short-term surgical outcomes, and long-term oncological results of 80 patients who received liver resection for HCC between January 2015 and December 2020 were analyzed (LLR, n=56; OLR, n=24). The average size of tumor in both groups were assessed for comparison.

Results: The average size of tumor was 50 mm in LLR and 80.3 mm in OLR. LLR is associated with less blood loss (p < 0.001), shorter length of hospital stay (p < 0.001), and lower morbidity rate (p = 0.034). The 5-year overall survival (OS) rates in the LLR group were significantly higher than those in the OLR group (81.3% vs. 27.5%; p = 0.020) and 5-year relapse free survival (55.1% vs 31.4%; p = 0.020).

The short-term outcomes were better in the LLR group in terms of blood loss, and length of hospital stay, and these benefits attenuated with advancing tumor size.

Conclusions: LLR for HCC is a safe and feasible procedure that has better short-term and long-term oncological outcomes in patients with tumor size less than 50 mm.

pISSN: 2508-5778ㆍeISSN: 2508-5859

Ann Hepatobiliary Pancreat Surg 2021;25 Suppl 1:S198 https://doi.org/10.14701/ahbps.LV-PP-4-4

Corresponding Author: Ruslan ALIKHANOV (r.alikhanov@mknc.ru) Presenter: Olesya SOLOVYEVA (e-mail)

Copyright Ⓒ The Korean Association of Hepato-Biliary-Pancreatic Surgery

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

참조

관련 문서

Understanding long-term relation and based on strategy, many countries were showing positive activities on involvement in clean up operations and striving for

“Transition-based dependency parsing with stack long short-term memory”, Proceedings of the 53 rd Annual Meeting of the Association for Computational

This study was conducted to investigate the effects of the long-term treatments of N, P, K fertilizers on fruits quality and yield, tree nutrition and

In Table 4, for the problems with 10, 20, and 30 nodes, the computational results of tabu search are shown with a recency based short term memory, a frequency based long term

Background The aim of this study was to compare the surgical outcomes of robotic single-site (RSS-H) and laparoendoscopic single-site total hysterectomy (LESS-H) and to

For example, short-term exposure to ozone has been associated with a higher risk of pneumonia in OBJECTIVES: The aim of this study was to estimate the age-specific effects

Long-term outcomes of short dental implants supporting single crowns in posterior region: a clinical retrospective study of 5-10 years.. Osteotome sinus

Effect of caloric restriction on the expression of PGC-1 and PPARs mRNA in liver of Otsuka Long-Evans Tokushima Fatty Rats.. Long-lived growth hormone